Broadwood Capital, 10% Owner: Lineage Cell Therapeutics LCTX Buy · Filed 25/01/28

Trade details

Type: Insider buy
Amount: $0
Shares · price: 0 sh · $0.00 a share
Held after: 49,560,992 sh
Stock: Lineage Cell Therapeutics LCTX
Person: Broadwood Capital10% Owner
Trade date: 25/01/27
Filed: 25/01/28
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 3 insiders
Holding change: under 0.1%

Lineage Cell Therapeutics trades, last 26 weeks

What else happened in Lineage Cell Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/28~25/02/26

Broadwood Capital's recent trades

Broadwood Capital10% Owner
BuyInsight Molecular Diagnostics
Buy
Insight Molecular Diagnostics
IMDX
$981.3K
280,381 sh
$981.3K
Filed 04/27
Traded 04/23
Broadwood Capital10% Owner
BuyInsight Molecular Diagnostics
Buy
Insight Molecular Diagnostics
IMDX
$913.4K
250,923 sh
$913.4K
Filed 04/27
Traded 04/27
Broadwood Capital10% Owner
BuyInsight Molecular Diagnostics
Buy
Insight Molecular Diagnostics
IMDX
$137.2K
38,880 sh
$137.2K
Filed 04/27
Traded 04/24
Broadwood Capital10% Owner
BuyInsight Molecular Diagnostics
Buy
Insight Molecular Diagnostics
IMDX
$0
0 sh
$0
Filed 04/27
Traded 04/24
Broadwood Capital10% Owner
BuyInsight Molecular Diagnostics
Buy
Insight Molecular Diagnostics
IMDX
$0
0 sh
$0
Filed 04/27
Traded 04/27

Broadwood Capital, 10% Owner — bought $0 of Lineage Cell Therapeutics LCTX · 0 sh @ $0.00 | Whalegun